Abstracts

Abate C. , Patel L. , Rauscher FJ III , and Curran T. (1990). Reduction of a single conserved cysteine residue in Fos and Jun regulates DNA-binding activity. Science 249: 1157-1161.

Abate C. , Luk D. , and Curran T. (1991). Transcriptional regulation by Fos and Jun in vitro: Interaction among multiple activator and regulatory domains. Mol. Cell. Biol. 11: 3624-3632.

Abate C. , Marshak DR , and Curran T. (1991). Fos is phosphorylated by p34cdc2, cAMP-dependent protein kinase and protein kinase C at multiple sites clustered within regulatory regions. Oncogene 6: 2179-2185.

Curran T. (1988). The fos Oncogene. In The Oncogene Handbook, EP Reddy ; AM Skalka and T Curran (eds). Elsevier, Amsterdam , pp. 307-325.

Curran T. and Franza BR Jr. (1988). Fos and Jun: The Ap-1 connection . Cell 55: 395-397.

Hai T. and Curran T. (1991). Fos/Jun and ATF/CREB cross-family dimerization alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88: 3720-3724. 7. Kerppola T. and Curran T. (1991). Fos-Jun hetero-dimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity. Cell 6: 317-326.

Kerppola TK and Curran T. (1991). DNA Bending by Fos and Jun: The Flexible Hinge Model. Science 254: 1210-1214.

Smeyne RJ , Schilling K. , Robertson L. , Luk D. , Oberdick J. , Curran T. , and Morgan JI (1992). Fos-lacZ Transgenic Mice: Mapping Sites of Gene Induction in the Central Nervous System. Neuron 8: 13-23.

Xanthoudakis A. and Curran T. (1992). Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 11: 653-665.

Angel P. et al (1987). Phorbol ester inducible genes contain a common cis element recognized by a TPAmodulated trans-acting factor. Cell 49: 729-739.

Angel, P. et al (1988b). The Jun proto-oncogene is positively autoregulated by its product, Jun/AP-1. Cell 55: 875-885.

Angel P. and Karin M. (1991). The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. BBA Reviews on Cancer 1072: 129-157.

Binteruy B. , Smeal T. , and Karin M. (1991). Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain. Nature 351: 122-127.

Boyle WJ et al (1991). Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 64: 573-584.

Buescher M. et al (1988). Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene 3: 301-311.

Chiu R. et al (1988). The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription from AP-1 responsive genes. Cell 54: 541-552.

Devary Y. et al (1991). Rapid and preferential activation of the c-jun gene during the mammalian UV response. Mol. Cell. Biol . 11: 2804-2811.

Greenberg ME and Ziff EB (1984). Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature 311: 433-438.

Holbrook NJ and Fornace AJ Jr. (1991). Responses to adversity: molecular control of gene activation following genotoxic stress . New Biol. 3: 825-833.

Karin M. (1990). The AP-1 complex and its role in transcriptional control by protein kinase C. In: Molecular Aspects of Cellular Regulation, Vol. 6, P Co-hen and G Foulkes (eds). Elsevier/North-Holland Biomedical Press , pp. 143-161.

Kruijer W. et al (1984). Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein. Nature 312: 711-716.

Lin A. et al (1992). Casein kinase II is a negative regulator of cJun DNA binding and AP-1 activity. Cell, in press.

Marais RM et al (1992). Casein kinase II phosphorylation increases the rate of serum response factor-binding site exchange. EMBO J 11: 97-105.

Norman C. et al (1988). Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell 55: 989-1003.

Pulverer BJ et al (1991). Phosphorylation of c-jun mediated by MAP kinases. Nature 353: 670-674.

Sasson-Corsi P. , Sisson JC , and Verma IM (1988). Transcriptional autoregulation of the proto-oncogene fos. Nature 334: 314-319.

Smeal T. et al (1992). Oncoprotein mediated signalling cascade stimulates cJun activity by phosphorylation of serines 63 and 73. Mol. Cell. Biol., in press.

Smeal T. et al (1991). Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of cJun on serines 63 and 73. Nature 354: 494-496.

Smeal T. et al (1989). Different requirements for formation of Jun:Jun and Jun:Fos complexes. Genes & Dev. 3: 2091-2100.

Treisman R. (1986). Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors . Cell 46: 567-574.

Yang-Yen H-F. , Chiu R. , and Karin M. (1990). Elevation of AP-1 activity during F9 cell differentiation is due to increased c-jun transcription. New Biol. 2: 351-361.

Brinkley BR , Valdivia MA , Tousson A. , and Brenner SL (1984). Compound kinetochores of the Indian Muntjac: Evolution by linear fusion of unit kinetochores. Chromosoma 91: 1-11.

Brinkley BR , Zinkowski RP , Mollon WL , Davis FM , Pisegna MA , Pershouse M. , and Rao PN (1988). Movement and segregation of kinetochores experimentally detached from mammalian chromosomes. Nature 336: 251-254.

Brinkley BR , Ouspenski II , and Zinkowski RP (1992). Structure and molecular organization of the centromere-kinetochore complex. Trends Cell Biol. 2: 15-21.

Clarke L. (1990). Centromeres of budding and fission yeast. Trends Genet. 6: 150-154.

Masumoto H. , Masukata H. , Muro Y. , Nozaki N. , and Okazaki T. (1989). A human centromere antigen (CENP-B) interacts with a short specific sequence in alphoid DNA, a human centromere satellite . J. Cell Biol. 109: 1963-1973.

Palmer DP , O'Day K. , and Margolis RL (1990). The centromere-specific histone CENP-A is selectively retained in discrete foci in mammalian sperm nuclei. Chromosoma 100: 32-36.

Zinkowski RP , Meyne J. , and Brinkley BR (1991). The centromere-kinetochore complex: A repeat subunit model. J. Cell Biol. 113: 1091-1110.

Otto E. , McCord S. , and Tlsty TD (1989) Increased incidence of CAD gene amplification in tumorigenic rat lines as an indicator of genomic instability of neoplastic cells. J. Biol. Chem. 264: 3390-3396.

Tlsty TD , Margolin B. , and Lum K. (1989) Differences in the rate of gene amplification in nontumorigenic and tumorigenic cell lines as measured by Luria-Delbrück fluctuation analysis. Proc. Natl. Acad. Sci. 86: 9441-9445.

Tlsty TD (1990) Normal diploid human and rodent cells lack a detectable frequency of gene amplification. Proc. Natl. Acad. Sci. 87: 3132-3136.

Tlsty TD , White A. , and Sanchez J. (1992) Suppression of gene amplification in human cell hybrids. Science 255: 1425-1427.

Bishop JM (1991). Molecular themes in oncogenesis. Cell 64: 235-248.

Finney R. and Bishop JM (1992). Manuscript in preparation.

Horvitz HR and Sternberg PW (1991). Multiple intercellular signalling systems control the development of the Caenorhabditis elegans vulva. Nature 351: 535-541.

Ridley AJ and Hall A. (1992). Function for Ras in sight. Nature 355: 497-498.

Rustgi AK , Dyson N. , and Bernards R. (1991). Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature 352: 541-544.

DiGiovanni J. , Walker SC , Beltran L. , Naito M. , and Eastin W. (1991). Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents. Cancer Res. 51: 1398-1405.

DiGiovanni J. , Imamoto A. , Sahi N. , Walker SE , Beltran L. , Chenicek KH , and Skow L. (1992). Further genetic analyses of skin tumor promoter susceptibility using inbred and recombinant inbred mice. Carcinogenesis 3: 525-531.

Fischer SM , O'Connell, J. , Conti CJ , Tacker KC , Fries JW , Patrick KE , Adams LM , and Slaga TJ (1987). Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. Carcinogenesis 8: 21-424.

Gimenez-Conti IB , Bianchi AB , Fischer , SM , Reiners JJ , Conti CJ , and Slaga TJ (1992). Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice. Cancer Res. 52: 3432-3435.

Imamoto A. , Beltran L. , Fujiki H. , Chenicek KH , and DiGiovanni J. (1992). Enhanced induction of epidermal ornithine decarboxylase activity in C57BL/6 compared to DBA/2 mice by protein kinase C-activating skin tumor promoters: Relevance to genetically mediated differences in promotion susceptibility, Carcinogenesis 13: 177-182.

Slaga TJ and Fischer SM (1983). Strain differences and solvent effects in mouse skin carcinogenesis experiments using carcinogens, tumor initiators and promoters . Prog. Exp. Tumor Res. 26: 85-109.

Brash DE , Rudolph JA , Simon JA , Lin A. , McKenna GJ , Baden HP , Halperin AJ , and Ponten J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88: 10124-10128.

Bressac B. , Kew M. , Wands J. , and Ozturk M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350: 429-431.

Gerwin BI , Spillare E. , Forrester K. , Lehman TA , Kispert J. , Welsh JA , Pfeifer AMA , Lechner JF , Baker SJ , Vogelstein B. , and Harris CC (1992). Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor type B1. Proc. Natl. Acad. Sci. USA 89: 2759-2763.

Hollstein M. , Sidransky D. , Vogelstein B. , and Harris CC (1991). p53 mutations in human cancers. Science 253: 49-53.

Hsu IC , Metcalf RA , Sun T. , Welsh J. , Wang NJ , and Harris CC (1991). p53 gene mutational hotspot in human hepatocellular carcinomas from Qidong, China. Nature 350: 427-428.

Ozturk M. (1991). p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 338: 1356-1359.

Bieberich CJ , Utset MF , Awgulewitsch A. , and Ruddle FH (1991). Evidence for positive and negative regulation of the Hox-3.1 gene. Proc. Natl. Acad. Sci. USA 87: 8462-8466.

Chisaka O. and Capecchi M. (1991). Regionally restricted developmental defects resulting from the targeted disruption of the mouse homeobox gene Hox-1.5. Nature 350: 473-479.

Kappen C. , Schughart K. , and Ruddle FH (1991). Two steps in the evolution of Antennapedia-class vertebrate homeobox genes. Proc. Natl. Acad. Sci. USA 86: 5459-5463.

Kessel M. and Gruss P. (1991). Homeotic transformation in murine prevertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell 67: 89-104.

Le Mouellic H. , Lallemand Y. , and Brulet P. (1991). Homeosis in the mouse induced by a null mutation in the Hox-3.1 gene. Cell 69: 251-264.

Magli MC , Barba P. , Celetti A. , De Vita G. , Cillo C. , and Boncinelli E. (1991). Coordinate regulation of HOX genes in human hematopoietic cells. Proc. Natl. Acad. Sci. USA 88: 6348-6352.

McGinnis W. and Krumlauf R. (1992). Homeobox genes and axial patterning. Cell 68: 283-302.

Perkins A. , Kongsuwan K. , Visvader J. , Adams JM , and Cory S. (1991). Homeobox gene expression plus autocrine growth factor production elicits myeloid leukemia. Proc. Natl. Acad. Sci. USA 87: 8398-8402.

Shashikant CS , Utset MF , Violette SM , Wise TL , Einat P. , Einat M. , Pendleton JW , Schughart K. , and Ruddle FH (1991). Homeobox genes in mouse development. Crit. Rev. Eukaryot. Gene Exp. 1: 207-245.

Hockenbery D. et al (1990). Nature 348: 334-336.

Hockenbery D. et al (1991). Proc. Natl. Acad . Sci. USA 88: 6961-6965.

McDonnell TJ et al (1989). Cell 57: 79-88.

Vaux DL et al (1988). Nature 335: 440-442.

Yonish-Rovach E. et al (1991). Nature 352: 345-347.

Bos JL (1989). ras oncogenes in human cancer: A review. Cancer Research 49: 4682-4689.

Harris CC (1989). Interindividual variation among humans in carcinogen metabolism, DNA adduct formation and DNA repair. Carcinogenesis 10: 1563-1566.

Hollstein M. , Sidransky D. , Vogelstein B. , and Harris CC (1991). p53 mutations in human cancers. Science 253: 49-53.

Hulka BS (1990). Overview of biological markers. In: Biological Markers in Epidemiology, B Hulka , T Wilcosky and J. Griffith , (eds). Oxford University Press, New York, pp. 3-15.

Perera FP (1987). Molecular cancer epidemiology: A new tool in cancer prevention. Jour. Nat. Cancer Inst. 78: 887-898.

Skipper PL and Tannenbaum SR (1990). Protein adducts in the molecular dosimetry of chemical carcinogens. Carcinogenesis 11: 507-518.

Wogan GN (1989). Markers of exposure to carcinogens. Environmental Health Perspectives 81: 9-17.

Heckbert SR , Weiss NS , Hornung SK et al (1992). Glutathione-S-transferase and epoxide hydrolase activity in human leukocytes in relation to the risk of lung and other smoking-related cancers. J. Natl. Cancer Inst. 84: 414-422.

Lave LB , Ennever FK , Rosenkranz HS et al (1988). Information value of the rodent bioassay . Nature 336: 631-633.

National Research Council ( 1983). Risk Assessment in the Federal Government: Managing the Process. National Academy Press, Washington, D.C.

National Research Council ( 1989a,b; 1991 a,b). Biomarkers of Reproductive and Developmental Toxicity; Biomarkers of Pulmonary Toxicology; Immunotoxicology; Neurotoxicology and Risk Assessment. National Academy Press , Washington, D.C.

Omenn GS , Lave LB ( 1988). Scientific and cost-effectiveness criteria in selecting batteries of short-term tests. Mutation Res. 205: 41-49.

Omenn GS , Omiecinski CJ , and Eaton DL (1990). Ecogenetics of chemical carcinogens. In: Biotechnology and Human Genetic Predisposition to Disease, CR Cantor , CT Caskey , LE Hood , D Kamely , a nd GS Omenn (eds). Wiley-Liss, Inc., New York, pp. 81-93.

Omenn GS et al (1992). Recruitment for the beta-Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in smokers and asbestos-exposed workers. Western J. Med. 156: 540-544.

Glick AB , Flanders KC , Danielpour D. , et al (1989). Retinoic acid induces transforming growth factor-β2 in cultured keratinocytes and mouse epidermis. Cell Regulation 1: 87-97.

Glick AB , Abdulkarem N. , Flanders KC , et al (1991). Complex regulation of TGF-β expression by retinoic in the vitamin A-deficient rat. Development 111: 1081-1086.

Kim SJ , Park K. , Koeller D. , et al (1992). Post-transcriptional regulation of the human transforming growth factor-β1 gene. J. Biol. Chem. 267: 13702-13707.

Roberts AB and Sporn MB (1991). The transforming growth factors-β. In: Peptide Growth Factors and Their Receptors, I, MB Sporn and AB Roberts (eds). Springer-Verlag, Heidelberg , pp. 419-472.

Roberts AB and Sporn MB (1992). Mechanistic interrelationships between two superfamilies: the steroid/ retinoid receptors and transforming growth factor-β. Cancer Surveys 14: 205-220.

Sporn MB and Roberts AB (1988). Peptide growth factors are multi-functional. Nature 332: 217-219.

Amstad PA et al (1991). The balance between Cu, Znsuperoxide dismutase and catalase affects the sensitivity of mouse epidermal cells to oxidative stress. Biochem. 30: 9305-9313.

Amstad P. , Krupitza G. , and Cerutti PA (1992). Mechanism of c-fos induction by active oxygen . Cancer Res. 52: 3952-3960.

Cerutti PA and Trump BF (1991). Inflammation and oxidative stress in carcinogenesis . Cancer Cells 3: 1-7.

Cerutti PA , Larsson R. , and Krupitza G. (1990). In Genetics Mechanisms in Carcinogenesis and Tumor Progression C Harris and LA Liotta (eds), Wiley-Liss, New York, pp. 69-82.

Chiocca SM , Sandy MS , and Cerutti PA (1992). Genotypic analysis of N-ethyl-N-nitrosourea-induced mutations by Taq I RFLP/PCR. Proc. Natl. Acad. Sci. USA 89: 5331-5335.

Felley-Bosco E. et al (1991). A genotypic mutation system measuring mutations in restriction recognition sequences. Nucl. Acid. Res. 19: 2913-2919.

Sandy M. , Chiocca S. , and Cerutti PA (1992). Genotypic analysis of mutations in Taq I restriction recognition sites by restriction fragment length polymorphism/ polymerase chain reaction. Proc. Natl. Acad. Sci. USA 89: 890-894.